153 related articles for article (PubMed ID: 11534486)
21. The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Fitzgerald JD
Postgrad Med J; 1976 Dec; 52(614):770-81. PubMed ID: 13355
[TBL] [Abstract][Full Text] [Related]
22. [Fibrinolytic treatment of acute myocardial infarction].
Aursnes I
Tidsskr Nor Laegeforen; 1989 Nov; 109(33):3435-6. PubMed ID: 2609306
[No Abstract] [Full Text] [Related]
23. Myocardial infarction: the first 24 hours.
Lipkin DP; Reid CJ
Br Med J (Clin Res Ed); 1988 Apr; 296(6627):947-8. PubMed ID: 2896039
[No Abstract] [Full Text] [Related]
24. [Adrenergic beta receptor blockaders].
Naess K
Tidsskr Nor Laegeforen; 1975 Feb; 95(6):380-3. PubMed ID: 235805
[No Abstract] [Full Text] [Related]
25. [Beta-adrenergic blocking agents and ventilatory function. Clinical aspects].
Monteiro-Trindade A; Costa-Trindade J; Palma-Carlos AG; de Padua F
Cah Med; 1973 Oct; 14(11):949-57. PubMed ID: 4151122
[No Abstract] [Full Text] [Related]
26. Clinical evaluation of practolol in acute arrhythmias.
Rymaszewski Z; Poplawska W; Preibisz J; Januszewicz W
Br Heart J; 1972 Mar; 34(3):260-2. PubMed ID: 4111392
[No Abstract] [Full Text] [Related]
27. Cutaneous side effects from beta-blockers and other antihypertensive agents.
Mobacken H
Acta Med Scand Suppl; 1979; 628():77-80. PubMed ID: 37708
[No Abstract] [Full Text] [Related]
28. Beta-adrenergic blocking agents in prevention of sudden death.
Chamberlain DA
Adv Cardiol; 1978; 25():196-205. PubMed ID: 30260
[No Abstract] [Full Text] [Related]
29. Percutaneous coronary intervention or thrombolytics in ST-elevation infarction. What is the emperor really wearing?
Dellborg M
Scand Cardiovasc J; 2002 Aug; 36(4):197-200. PubMed ID: 12201965
[No Abstract] [Full Text] [Related]
30. [Beta blockage after myocardial infarct].
Frick MH; Katila M
Duodecim; 1982; 98(2):150-7. PubMed ID: 6120827
[No Abstract] [Full Text] [Related]
31. Is there still a place for practolol?
Drug Ther Bull; 1975 Aug; 13(18):72. PubMed ID: 1157650
[No Abstract] [Full Text] [Related]
32. Post-myocardial infarction trials: beta blockers, antiarrhythmics, thrombolytics.
Anderson JL
Control Clin Trials; 1996 Jun; 17(3 Suppl):17S-27S. PubMed ID: 8877264
[TBL] [Abstract][Full Text] [Related]
33. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Frishman WH; Furberg CD; Friedewald WT
Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
[No Abstract] [Full Text] [Related]
34. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Frishman WH
Am Heart J; 1980 Apr; 99(4):528-36. PubMed ID: 6102436
[No Abstract] [Full Text] [Related]
35. Hypotensive agents, beta-blockers, and drug-induced lupus.
Hughes GR
Br Med J (Clin Res Ed); 1982 May; 284(6326):1358-9. PubMed ID: 6122487
[No Abstract] [Full Text] [Related]
36. [Fibrinolytic treatment of acute myocardial infarction].
Hoechst N
Tidsskr Nor Laegeforen; 1990 Jan; 110(2):248. PubMed ID: 2300965
[No Abstract] [Full Text] [Related]
37. Editorial: Beta-blockers and the eye.
Br J Ophthalmol; 1976 May; 60(5):311. PubMed ID: 8075
[No Abstract] [Full Text] [Related]
38. beta-Adrenergic blocking agents in the post-myocardial infarction patient.
Goldstein S
Arch Intern Med; 1979 Oct; 139(10):1089-90. PubMed ID: 39535
[No Abstract] [Full Text] [Related]
39. Early intravenous beta blockade and thrombolytics in acute myocardial infarction.
Olsson G; Held P
Am J Cardiol; 1993 Dec; 72(19):156G-160G. PubMed ID: 7904119
[TBL] [Abstract][Full Text] [Related]
40. The role of long term beta-blockade after myocardial infarction: Paper 3.
Wilkinson RK
Aust Fam Physician; 1978 Jun; Suppl():38-9. PubMed ID: 30443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
